March 13, 2026
1 min read

FDA fires off another manufacturing-related CRL, this one to Hyloris

The FDA has rejected Hyloris Pharmaceuticals’ antiviral valacyclovir, an oral suspension for infections caused by herpes simplex and varicella-zoster viruses becasue of manufacturing problems.

Leave a Reply

Your email address will not be published.

Previous Story

Nutrition

Next Story

FDA scolds CDMO Simtra with warning letter over contamination fumbles

Previous Story

Nutrition

Next Story

FDA scolds CDMO Simtra with warning letter over contamination fumbles

Latest from Blog

NEWS CENTER Maine

Through in-depth storytelling, through direct contact on digital on social platforms, through long-standing community service programs like Coats & Toys for Kids, Project Heat and Buddy to Buddy, NEWS CENTER Maine is
Go toTop